Reply to: "Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19".
Laura Ambra NicoliniMalgorzata MikulskaAlessio SignoriAntonio Di BiagioFederica PortunatoAntonio VenaMauro GiacominiMatteo BassettiPublished in: Open forum infectious diseases (2020)